{"id":1684,"date":"2020-09-22T09:48:04","date_gmt":"2020-09-22T09:48:04","guid":{"rendered":"https:\/\/leyton.majjane.agency\/uk\/insights\/case-study\/destina-genomics\/"},"modified":"2026-07-26T19:19:52","modified_gmt":"2026-07-26T17:19:52","slug":"destina-genomics","status":"publish","type":"case_study","link":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/","title":{"rendered":"Destina Genomics"},"content":{"rendered":"<figure class=\"wp-block-image aligncenter\"><img decoding=\"async\" src=\"https:\/\/leyton.com\/uk\/wp-content\/blogs.dir\/9\/files\/2020\/09\/Destina-genomics-1.jpg\" alt=\"Hugh Ilyine, Destina Genomics\"\/><\/figure>\n<blockquote class=\"wp-block-quote\">\n<p>There is a feeling of support that comes not only from the British government providing this funding, but also from working with Leyton. Leyton\u2019s work has been very rewarding for us, not just financially but also in terms of the motivation, headspace and management of the company<\/p>\n<p><cite>\u2014 Hugh Ilyine, Destina Genomics<\/cite><\/p><\/blockquote>\n<h2>Innovation<\/h2>\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/leyton.com\/uk\/wp-content\/blogs.dir\/9\/files\/2020\/09\/GettyImages-694987801_711x455px.jpg\" alt=\"Innovation\"\/><\/figure>\n<p>Destina Genomics uses their unique, patented chemistry to accurately detect nucleic acid biomarkers in biological fluids such as blood serum and plasma, urine and saliva. With simpler protocols and high specificity, accurate direct quantification of short RNA biomarkers is now possible in biological fluids such as blood plasma and urine, a truly innovative advance over traditional tissue based pathology procedures.<\/p>\n<h2>Results<\/h2>\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/leyton.com\/uk\/wp-content\/blogs.dir\/9\/files\/2020\/09\/pexels-fauxels-3184405_711x455px.jpg\" alt=\"Results\"\/><\/figure>\n<p>By learning about their client needs, Leyton developed a \u2018stress free\u2019 process for the engagement, and an end results success. With a broad experience of working with other consultants, the client commented that Leyton had a contributory and balanced approach, with all the work prepared in a timely and friendly manner. Leyton was able to facilitate a quick turnaround during periods where the business faced time and project priority constraints.<\/p>\n<p>Our in-house team of highly experienced scientists, engineers, tax consultants and attorneys would love to answer all your questions and help you make the most out of your R&#038;D efforts.<\/p>\n<ul>\n<li>Global experience<\/li>\n<li>Maximize your claim<\/li>\n<li>Audit Support<\/li>\n<li>Team of Experts<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>There is a feeling of support that comes not only from the British government providing this funding, but also from working with Leyton. Leyton\u2019s work has been very rewarding for us, not just financially but also in terms of the motivation, headspace and management of the company \u2014 Hugh Ilyine, Destina Genomics Innovation Destina Genomics [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1230,"menu_order":0,"template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[125,138],"tags":[],"expertise":[],"class_list":["post-1684","case_study","type-case_study","status-publish","has-post-thumbnail","hentry","category-health-and-pharma","category-rd-tax-credits"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.1 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Leyton enabled DestiNA Genomics to claim tax relief<\/title>\n<meta name=\"description\" content=\"There is a feeling of support that comes from the British government providing this funding and from working with Leyton which has developed a &#039;stress free&#039; process.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Destina Genomics\" \/>\n<meta property=\"og:description\" content=\"There is a feeling of support that comes from the British government providing this funding and from working with Leyton which has developed a &#039;stress free&#039; process.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/\" \/>\n<meta property=\"og:site_name\" content=\"Leyton\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-26T17:19:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/leyton.com\/wp-content\/blogs.dir\/9\/files\/2020\/09\/Science_DNA_RGB.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1169\" \/>\n\t<meta property=\"og:image:height\" content=\"877\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/insights\\\/case-study\\\/destina-genomics\\\/\",\"url\":\"https:\\\/\\\/leyton.com\\\/uk\\\/insights\\\/case-study\\\/destina-genomics\\\/\",\"name\":\"Leyton enabled DestiNA Genomics to claim tax relief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/insights\\\/case-study\\\/destina-genomics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/insights\\\/case-study\\\/destina-genomics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/9\\\/files\\\/2020\\\/09\\\/Science_DNA_RGB.jpg\",\"datePublished\":\"2020-09-22T09:48:04+00:00\",\"dateModified\":\"2026-07-26T17:19:52+00:00\",\"description\":\"There is a feeling of support that comes from the British government providing this funding and from working with Leyton which has developed a 'stress free' process.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/insights\\\/case-study\\\/destina-genomics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/leyton.com\\\/uk\\\/insights\\\/case-study\\\/destina-genomics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/insights\\\/case-study\\\/destina-genomics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/9\\\/files\\\/2020\\\/09\\\/Science_DNA_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/9\\\/files\\\/2020\\\/09\\\/Science_DNA_RGB.jpg\",\"width\":1169,\"height\":877,\"caption\":\"3D medical background with DNA strand\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/insights\\\/case-study\\\/destina-genomics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/leyton.com\\\/uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Destina Genomics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/leyton.com\\\/#website\",\"url\":\"https:\\\/\\\/leyton.com\\\/\",\"name\":\"Leyton\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/leyton.com\\\/uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/#organization\",\"name\":\"Leyton\",\"url\":\"https:\\\/\\\/leyton.com\\\/uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/9\\\/files\\\/2026\\\/01\\\/logo.svg\",\"contentUrl\":\"https:\\\/\\\/leyton.com\\\/wp-content\\\/blogs.dir\\\/9\\\/files\\\/2026\\\/01\\\/logo.svg\",\"width\":108,\"height\":44,\"caption\":\"Leyton\"},\"image\":{\"@id\":\"https:\\\/\\\/leyton.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Leyton enabled DestiNA Genomics to claim tax relief","description":"There is a feeling of support that comes from the British government providing this funding and from working with Leyton which has developed a 'stress free' process.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/","og_locale":"en_US","og_type":"article","og_title":"Destina Genomics","og_description":"There is a feeling of support that comes from the British government providing this funding and from working with Leyton which has developed a 'stress free' process.","og_url":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/","og_site_name":"Leyton","article_modified_time":"2026-07-26T17:19:52+00:00","og_image":[{"width":1169,"height":877,"url":"https:\/\/leyton.com\/wp-content\/blogs.dir\/9\/files\/2020\/09\/Science_DNA_RGB.jpg","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/","url":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/","name":"Leyton enabled DestiNA Genomics to claim tax relief","isPartOf":{"@id":"https:\/\/leyton.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/#primaryimage"},"image":{"@id":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/#primaryimage"},"thumbnailUrl":"https:\/\/leyton.com\/wp-content\/blogs.dir\/9\/files\/2020\/09\/Science_DNA_RGB.jpg","datePublished":"2020-09-22T09:48:04+00:00","dateModified":"2026-07-26T17:19:52+00:00","description":"There is a feeling of support that comes from the British government providing this funding and from working with Leyton which has developed a 'stress free' process.","breadcrumb":{"@id":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/#primaryimage","url":"https:\/\/leyton.com\/wp-content\/blogs.dir\/9\/files\/2020\/09\/Science_DNA_RGB.jpg","contentUrl":"https:\/\/leyton.com\/wp-content\/blogs.dir\/9\/files\/2020\/09\/Science_DNA_RGB.jpg","width":1169,"height":877,"caption":"3D medical background with DNA strand"},{"@type":"BreadcrumbList","@id":"https:\/\/leyton.com\/uk\/insights\/case-study\/destina-genomics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/leyton.com\/uk\/"},{"@type":"ListItem","position":2,"name":"Destina Genomics"}]},{"@type":"WebSite","@id":"https:\/\/leyton.com\/#website","url":"https:\/\/leyton.com\/","name":"Leyton","description":"","publisher":{"@id":"https:\/\/leyton.com\/uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leyton.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/leyton.com\/uk\/#organization","name":"Leyton","url":"https:\/\/leyton.com\/uk\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/leyton.com\/uk\/#\/schema\/logo\/image\/","url":"https:\/\/leyton.com\/wp-content\/blogs.dir\/9\/files\/2026\/01\/logo.svg","contentUrl":"https:\/\/leyton.com\/wp-content\/blogs.dir\/9\/files\/2026\/01\/logo.svg","width":108,"height":44,"caption":"Leyton"},"image":{"@id":"https:\/\/leyton.com\/uk\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/case_study\/1684","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/types\/case_study"}],"author":[{"embeddable":true,"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":3,"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/case_study\/1684\/revisions"}],"predecessor-version":[{"id":13065,"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/case_study\/1684\/revisions\/13065"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/media\/1230"}],"wp:attachment":[{"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/media?parent=1684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/categories?post=1684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/tags?post=1684"},{"taxonomy":"expertise","embeddable":true,"href":"https:\/\/leyton.com\/uk\/wp-json\/wp\/v2\/expertise?post=1684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}